Table 1.
Mutation | Promoter | Phenotype | References |
Hras+ (low copy) Hras+ (high copy) |
UPII UPII |
Low grade, non-invasive (long latency) Low grade, non-invasive (short latency) |
Zhang, 200144 Zhang, 200144 |
Egfr+ Egfr+Hras+ |
UPII UPII |
Hyperplasia Hyperplasia |
Cheng, 200245 Cheng, 200245 |
Fgfr3+ Fgfr3+KrasG12D Fgfr3+β-cateninexon3/+ Fgfr3+Ptenfl/fl |
UPII UPII UPII UPII |
Hyperplasia Hyperplasia Hyperplasia Hyperplasia |
Ahmad, 201146 Ahmad, 201146 Ahmad, 201146 Foth, 201447 |
Ncstnfl/fl | R26rtTA; tetO- | Invasive UCC | Rampias, 201448 |
p53fl/fl p53fl/fl p53fl/flHras+ p53fl/flPtenfl/fl |
UPII UPKII UPII Adeno-Cre |
Hyperplasia and dysplasia No phenotype High grade, invasive UCC Invasive, metastatic UCC |
Gao, 200449 Ayala de la Peña, 201150 Gao, 200449 Puzio-Kuter, 200951 |
Ptenfl/fl Ptenfl/fl Ptenfl/fl Ptenfl/fl |
Fabp-Cre Ksp-Cre Adeno-Cre UPII |
Low grade UCC UCC of renal pelvis No phenotype No phenotype |
Yoo, 2006,52 Tsuruta, 200653 Qian, 200954 Puzio-Kuter, 200951 Ahmad, 201134 |
Rb-/- Rb-/-Ptenfl/fl Rb-/-p53fl/fl |
UPII Adeno-Cre UPII |
No phenotype No phenotype Invasive UCC after chemical carcinogenesis |
He, 200955 Puzio-Kuter, 200951 He, 200955 |
SV40 T antigen (low copy) SV40 T antigen (high copy) SV40 T antigen |
UPII UPII UPKII |
Carcinoma in situ Invasive, metastatic UCC Carcinoma in situ |
Zhang, 199956 Zhang, 199956 Ayala de la Peña, 201150 |
β-cateninexon3/+ β-cateninexon3/+Ptenfl/fl β-cateninexon3/+HrasQ61L |
UPII UPII UPII |
Hyperplasia Low grade, non-invasive UCC Low grade, non-invasive UCC |
Ahmad, 201134 Ahmad, 201134 Ahmad, 201135 |
UCC = urothelial cell carcinoma |